THE COST-EFFECTIVENESS OF ISOTRETINOIN IN PATIENTS WITH MODERATE-TO-SEVERE ACNE VULGARIS

被引:0
|
作者
Shin, J. [1 ]
Hay, J. [1 ]
机构
[1] Univ So Calif, Los Angeles, CA USA
关键词
D O I
10.1016/S1098-3015(10)72709-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A146 / A146
页数:1
相关论文
共 50 条
  • [1] No association between isotretinoin and impulsivity in patients with moderate-to-severe acne vulgaris
    Ogut, Cagri
    Ogut, Neslihan D.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (04) : 484 - 490
  • [2] Isotretinoin-induced inflammatory back pain and sacroiliitis in patients with moderate-to-severe acne vulgaris
    Civelek, Unzule Seyman
    Selcuk, Leyla Baykal
    Arica, Deniz Aksu
    Capkin, Erhan
    Yayli, Savas
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (10) : 4846 - 4851
  • [3] Effect of oral isotretinoin therapy on thyroid function in patients with moderate-to-severe acne vulgaris: A prospective study
    AlSaif, Fahad
    AlOtaibi, Hend
    Balbisi, Amal
    AlAmari, Ahmad
    AlSaif, Faisal
    AlAmari, AlBatool
    AlDakhil, Abdulrhman
    AlModayfer, Arwa
    AlSyefi, Nourah
    JOURNAL OF DERMATOLOGY & DERMATOLOGIC SURGERY-JDDS, 2020, 24 (01): : 38 - 40
  • [4] The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis
    Rouse, Nicole C.
    Farhangian, Michael E.
    Wehausen, Brooke
    Feldman, Steven R.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 877 - 884
  • [5] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [6] Isotretinoin induces dermcidin expression in patients with moderate to severe acne vulgaris
    Ragab, Magdy
    Omar, Salma
    Abo El-Wafa, Reham
    Sultan, Eman
    Gomaa, Neveen
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2019, 16 (01): : 56 - 62
  • [7] Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China
    Tian, Lei
    Xiong, Xiaomo
    Guo, Qiang
    Chen, Yixi
    Wang, Luying
    Dong, Peng
    Ma, Aixia
    PHARMACOECONOMICS, 2020, 38 (12) : 1345 - 1358
  • [8] Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China
    Lei Tian
    Xiaomo Xiong
    Qiang Guo
    Yixi Chen
    Luying Wang
    Peng Dong
    Aixia Ma
    PharmacoEconomics, 2020, 38 : 1345 - 1358
  • [9] COST-EFFECTIVENESS OF APREMILAST IN MODERATE-TO-SEVERE PSORIASIS IN CANADA
    Cawston, H.
    Damera, V
    Ektare, V
    Shear, N. H.
    Tencer, T.
    Liu, F. F.
    VALUE IN HEALTH, 2016, 19 (07) : A587 - A587
  • [10] Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis
    Tsao, Nicole W.
    Shojania, Kam
    Marra, Carlo A.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (01) : 9 - 18